摘要
糖尿病是一种代谢性疾病,在过去的几十年里,它已成为导致青年和中年发病率和死亡率的一个重要原因,它是第四大导致死亡的疾病。1型和2型糖尿病严重的发病机制会引起微血管并发症如肾病、视网膜病变和神经病变和大血管并发症:心血管疾病,心脏病发作和中风。高血糖状态下,不同信号转导机制的激活、多元醇通路的增加、晚期糖基化终产物的形成、蛋白激酶C和己糖胺通路的激活导致活性氧的过度表达,并导致糖尿病并发症的发病机制。了解糖尿病并发症中这些途径对身体第二系统所造成的损害十分重要。在过去的十年中,对这些生化变化的理解有了很大的进展,许多分子已被利用作为糖尿病并发症的治疗靶点。本文简要介绍了糖尿病和慢性并发症,并对细胞/分子机制和新治疗方法的靶向治疗的最新研究进展进行了讨论
关键词: 糖尿病,并发症,信号传导机制,抗糖尿病药物,靶向治疗。
图形摘要
Current Drug Targets
Title:Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Volume: 17 Issue: 11
Author(s): Krishna A. Adeshara, Arundhati G. Diwan, Rashmi S. Tupe
Affiliation:
关键词: 糖尿病,并发症,信号传导机制,抗糖尿病药物,靶向治疗。
摘要: Diabetes is a metabolic disorder and over the past decades, it has become a major cause of morbidity and mortality affecting the youth and middle-aged as it is the fourth leading cause of disease related to death. In both type 1 and type 2 diabetes the severe pathogenesis cause micro vascular complications: nephropathy, retinopathy, neuropathy and macro vascular complications: cardiovascular disease, heart attacks and stroke. Under hyperglycemia, activation of different signaling mechanisms such as an increased polyol pathway, advanced-glycation end product formation, activation of Protein Kinase C and hexosamine pathway leads to the over expression of reactive oxygen species and causes pathogenesis of diabetic complications. It is necessary to understand these pathways in diabetic complications causing damage to the secondary system of the body. In the past decade the understanding of these biochemical changes has increased tremendously and various molecules have been exploited as therapeutic targets for diabetic complications as better therapeutic approach. In this review, a brief overview about diabetes mellitus and chronic complications with their current understandings of cellular/molecular mechanisms and targeted therapies along with novel therapeutic strategies is discussed.
Export Options
About this article
Cite this article as:
Krishna A. Adeshara, Arundhati G. Diwan, Rashmi S. Tupe , Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies, Current Drug Targets 2016; 17 (11) . https://dx.doi.org/10.2174/1389450117666151209124007
DOI https://dx.doi.org/10.2174/1389450117666151209124007 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Properties of the Mesenchymal Endometriotic Stem Cell in the Context of the Immune System and Analysis of its Role in Endometriosis
Recent Patents on Regenerative Medicine Quick-Release Bromocriptine for Treatment of Type 2 Diabetes
Current Drug Delivery Aminoacid Support in the Prevention of Diabetes and Diabetic Complications
Current Protein & Peptide Science Antidiabetics Interactions with Herbs: A Compressive Review
Current Diabetes Reviews Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Putting Evidence for Diabetes Care into Practice
Current Diabetes Reviews Pitavastatin and 4-Hydroxy-3-Methoxyacetophenone (HMAP) Reduce Cognitive Dysfunction in Vascular Dementia During Experimental Diabetes
Current Neurovascular Research Purinergic Signalling and Endothelium
Current Vascular Pharmacology On Epistasis: A Methodological Review for Detecting Gene-Gene Interactions Underlying Various Types of Phenotypic Traits
Recent Patents on Biotechnology Stages of HIV Replication and Targets for Therapeutic Intervention
Current Topics in Medicinal Chemistry Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design Small Molecules as Potent Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors Documented in Patents from 2009 to 2013
Mini-Reviews in Medicinal Chemistry Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids
Current Medicinal Chemistry Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair
CNS & Neurological Disorders - Drug Targets Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Current Topics in Medicinal Chemistry Other Potential Therapeutic Targets in Thyroid Orbitopathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Challenges in Vascular Repair by Endothelial Progenitor Cells in Diabetic Patients
Cardiovascular & Hematological Disorders-Drug Targets Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons
Current Drug Targets Genomic Organization and Control of the Grb7 Gene Family
Current Genomics Long-lasting Insulin Treatment Via a Single Subcutaneous Administration of Liposomes in Thermoreversible Pluronic® F127 Based Hydrogel
Current Pharmaceutical Design